Mini Nicotine Lozenge
Product Images NDC 79481-0734

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mini Nicotine (NDC 79481-0734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meijer, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

734-6e-mini-nicotine-lozenge.jpg (734 6e Mini Nicotine Lozenge)

Mini Nicotine Lozenge 2 mg with active ingredient Nicotine Polacrilex in mint flavor is an oral stop smoking aid by Meijer, Inc. The packaging contains 20 sugar-free and gluten-free lozenges. The carton includes drug facts, warnings, usage directions, and a tamper-evident feature note. It also shows an image of the blue bottle packaging and highlights comparison to Nicorette Mini Lozenge.*

FDA Label Image

Wallet Card Image 1 (Image 01)

An illustrated wallet card titled 'My most important reasons to quit smoking are:', containing five blank lines for the user to write personal reasons for quitting smoking. The card has a thin border and no additional text or graphics.*

FDA Label Image

Wallet Card Image 2 (Image 02)

A wallet card listing helpline phone numbers for quitting support: American Lung Association, American Cancer Society, and American Heart Association, with a note to contact a quitting buddy or friend who has quit. The text is in black on a white background with a gray border.*

FDA Label Image

Smoke Free Habits Logo (Image 03)

FDA Label Image

Upc Example (Image 04)

The image shows a barcode with the text 'EXAMPLE UPC ONLY' in red overlaying it. The barcode includes the numbers 0 12345 67890 beneath the lines.*

FDA Label Image

Reminder Stickers (Image 05)

An illustrated reminder guide for mini nicotine lozenge use, showing a schedule with steps 1 to 3 for lozenge intake intervals starting from week 1, and an 'Ex-Smoker' marker for 12 weeks after the quit date. The steps include usage frequencies at weeks 1, 7, and 10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.